Nalaganje...
IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling
Mesenchymal stem cells (MSCs) hold great promise as potential therapies for tumors through the delivery of various anticancer agents. However, exogenous tissue-derived MSCs, such as those of bone marrow, have exhibited a tendency for malignant transformation in the tumor microenvironment. This issue...
Shranjeno v:
| izdano v: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6412447/ https://ncbi.nlm.nih.gov/pubmed/30816520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|